Capital Research Global Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Capital Research Global Investors’s Portfolio BMRN Stock Details BMRN Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$21.5M	Sell	391,879 -8,758,776	-96%	-$481M	﹤0.01%	391
2025 Q1	$647M	Sell	9,150,655 -3,841,117	-30%	-$272M	0.14%	126
2024 Q4	$854M	Buy	12,991,772 +2,496,817	+24%	+$164M	0.18%	114
2024 Q3	$738M	Buy	10,494,955 +802,389	+8%	+$56.4M	0.15%	118
2024 Q2	$798M	Buy	9,692,566 +3,171,905	+49%	+$261M	0.18%	111
2024 Q1	$570M	Sell	6,520,661 -4,253,980	-39%	-$372M	0.13%	139
2023 Q4	$1.04B	Buy	10,774,641 +4,756,671	+79%	+$459M	0.26%	88
2023 Q3	$532M	Sell	6,017,970 -738,062	-11%	-$65.3M	0.15%	137
2023 Q2	$586M	Sell	6,756,032 -452,927	-6%	-$39.3M	0.16%	130
2023 Q1	$701M	Buy	7,208,959 +1,557,958	+28%	+$151M	0.2%	107
2022 Q4	$585M	Buy	5,651,001 +714,261	+14%	+$73.9M	0.18%	122
2022 Q3	$418M	Buy	4,936,740 +1,394	+0%	+$118K	0.14%	146
2022 Q2	$409M	Sell	4,935,346 -4,452,610	-47%	-$369M	0.13%	149
2022 Q1	$724M	Sell	9,387,956 -3,284,052	-26%	-$253M	0.18%	115
2021 Q4	$1.12B	Sell	12,672,008 -4,973,431	-28%	-$439M	0.25%	94
2021 Q3	$1.36B	Sell	17,645,439 -4,440,950	-20%	-$343M	0.32%	80
2021 Q2	$1.84B	Buy	22,086,389 +10,024	+0%	+$836K	0.43%	57
2021 Q1	$1.67B	Sell	22,076,365 -2,592	-0%	-$196K	0.41%	56
2020 Q4	$1.94B	Buy	22,078,957 +15,695	+0.1%	+$1.38M	0.5%	41
2020 Q3	$1.68B	Sell	22,063,262 -2,514	-0%	-$191K	0.5%	41
2020 Q2	$2.72B	Buy	22,065,776 +25,158	+0.1%	+$3.1M	0.86%	26
2020 Q1	$1.86B	Buy	22,040,618 +36,553	+0.2%	+$3.09M	0.73%	29
2019 Q4	$1.86B	Buy	22,004,065 +296,401	+1%	+$25.1M	0.56%	46
2019 Q3	$1.46B	Buy	21,707,664 +2,011,459	+10%	+$136M	0.48%	53
2019 Q2	$1.69B	Buy	19,696,205 +1,947,144	+11%	+$167M	0.54%	50
2019 Q1	$1.58B	Sell	17,749,061 -555,102	-3%	-$49.3M	0.5%	52
2018 Q4	$1.56B	Sell	18,304,163 -1,244,970	-6%	-$106M	0.54%	51
2018 Q3	$1.9B	Sell	19,549,133 -2,043,999	-9%	-$198M	0.55%	43
2018 Q2	$2.03B	Buy	21,593,132 +92,281	+0.4%	+$8.69M	0.56%	46
2018 Q1	$1.74B	Sell	21,500,851 -8	-0%	-$649	0.5%	55
2017 Q4	$1.92B	Buy	21,500,859 +650,258	+3%	+$58M	0.56%	52
2017 Q3	$1.94B	Buy	20,850,601 +1,951,902	+10%	+$182M	0.59%	46
2017 Q2	$1.72B	Sell	18,898,699 -744,734	-4%	-$67.6M	0.54%	49
2017 Q1	$1.72B	Buy	19,643,433 +390	+0%	+$34.2K	0.54%	51
2016 Q4	$1.63B	Sell	19,643,043 -573,172	-3%	-$47.5M	0.53%	54
2016 Q3	$1.87B	Buy	20,216,215 +4,362,912	+28%	+$404M	0.62%	44
2016 Q2	$1.23B	Buy	15,853,303 +8	+0%	+$622	0.42%	65
2016 Q1	$1.31B	Sell	15,853,295 -2,134,806	-12%	-$176M	0.45%	61
2015 Q4	$1.88B	Sell	17,988,101 -952,119	-5%	-$99.7M	0.64%	42
2015 Q3	$1.99B	Sell	18,940,220 -697,601	-4%	-$73.5M	0.71%	36
2015 Q2	$2.69B	Buy	19,637,821 +143,705	+0.7%	+$19.7M	0.88%	25
2015 Q1	$2.43B	Buy	19,494,116 +1,429,587	+8%	+$178M	0.83%	27
2014 Q4	$1.63B	Buy	18,064,529 +42,716	+0.2%	+$3.86M	0.55%	44
2014 Q3	$1.3B	Buy	18,021,813 +145,800	+0.8%	+$10.5M	0.45%	58
2014 Q2	$1.11B	Buy	17,876,013 +98,420	+0.6%	+$6.12M	0.39%	69
2014 Q1	$1.21B	Buy	17,777,593 +356,609	+2%	+$24.3M	0.44%	62
2013 Q4	$1.22B	Buy	17,420,984 +74,300	+0.4%	+$5.22M	0.45%	61
2013 Q3	$1.25B	Buy	17,346,684 +377,938	+2%	+$27.3M	0.49%	54
2013 Q2	$947M	Buy	+16,968,746	New	+$947M	0.4%	69